Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
2.
Scand J Immunol ; 86(2): 83-90, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28513991

RESUMEN

Hymenolepis nana is the most commonly known intestinal cestode infecting mainly human. This study aimed to investigate the potential effect of chitosan particles (CSP) to enhance the immune system against H. nana infection. Determination of worm burden, egg output, histopathological changes, oxidative stress markers (lipid peroxidation and reduced glutathione), goblet (GCs) and mucosal mast cells (MMCs) counts in intestinal ileum was performed. In addition, levels of intestinal mRNA expression of interleukin (IL)-4, IL-9, stem cell factor (SCF), type I and II interferons (IFN)-α/ γ, tumour necrosis factor (TNF)-α, mucin 2 (MUC2) and inducible nitric oxide synthase (iNOs) were investigated using real-time PCR. The results indicated induced reductions in adult worm and egg counts in infected mice after CSP treatment. This was associated with improvement in tissue morphometric measurements and oxidative stress which were altered after infection. Expression levels of iNOs, IFN-α, IFN-γ, TNF-α and IL-9 were decreased by CSP. Conversely, expression levels of MUC2, IL-4 and SCF increased compared to infected untreated group. In addition, GCs and MMCs counts were normalized by CSP. In conclusion, this study could indicate the immunoprotective effect of CSP against H. nana infection. This was characterized with Th2 anti-inflammatory responses.


Asunto(s)
Quitosano/farmacología , Himenolepiasis/prevención & control , Hymenolepis nana/efectos de los fármacos , Intestinos/efectos de los fármacos , Animales , Quitosano/química , Quitosano/inmunología , Citocinas/genética , Citocinas/inmunología , Citocinas/metabolismo , Expresión Génica/efectos de los fármacos , Expresión Génica/inmunología , Proteínas del Helminto/genética , Proteínas del Helminto/inmunología , Proteínas del Helminto/metabolismo , Interacciones Huésped-Parásitos/efectos de los fármacos , Interacciones Huésped-Parásitos/inmunología , Humanos , Himenolepiasis/inmunología , Himenolepiasis/parasitología , Hymenolepis nana/inmunología , Hymenolepis nana/fisiología , Interferón-alfa/genética , Interferón-alfa/inmunología , Interferón-alfa/metabolismo , Interferón gamma/genética , Interferón gamma/inmunología , Interferón gamma/metabolismo , Interleucina-4/genética , Interleucina-4/inmunología , Interleucina-4/metabolismo , Intestinos/inmunología , Intestinos/parasitología , Ratones , Mucina 2/genética , Mucina 2/inmunología , Mucina 2/metabolismo , Óxido Nítrico Sintasa de Tipo II/genética , Óxido Nítrico Sintasa de Tipo II/inmunología , Óxido Nítrico Sintasa de Tipo II/metabolismo , Recuento de Huevos de Parásitos , Tamaño de la Partícula , Sustancias Protectoras/farmacología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología , Factor de Necrosis Tumoral alfa/metabolismo
3.
PLoS Negl Trop Dis ; 10(12): e0005147, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27923058

RESUMEN

Bolivia is one of the countries with a high intestinal helminth and protozoan infection rate. Despite the high prevalence of the parasitic infection, nationwide preventive measures for Bolivian children have not yet been implemented. We evaluated the effect of mass stool examination and treatment as a strategy for decreasing the infection rate. This study was conducted between 2013 and 2015 in children aged 2-18 years. A total of 2,033 stool samples (575 in 2013, 815 in 2014 and 642 in 2015) were collected and examined using the formalin-ether medical sedimentation method. As an anthelminthic medicine, nitazoxanide was given to all infected children within 2 months post-examination, each year. The effect of mass stool examination and treatment was evaluated based on the changes in the overall or individual parasitic infection rates during the study period. The overall parasitic infection rate decreased significantly from 65.2% in 2013 to 43.0% in 2015; a 22.2 percentage point decrease (P<0.001). Protozoan infection accounted for a large portion of the parasitic infections, in the following rates: 62.4% in 2013, 49.3% in 2014, and 41.0% in 2015. The rate of the most common helminth infection, Hymenolepis nana, decreased significantly from 9.0% in 2013 to 6.4% in 2014 to 3.4% in 2015 (P<0.001). Prevalence of the most common pathogenic protozoan infection, Entamoeba histolytica, decreased significantly from 19.0% in 2013 to 3.0% in 2015 (P<0.001). Conversely, the rate of Giardia intestinalis increased significantly from 16.5% in 2013 to 21.2% in 2015 (P<0.01). Mass stool examination and treatment for intestinal helminth and protozoan infections was effective for decreasing the overall parasitic infection rate in the study population, excluding Giardia intestinalis. Further studies on the long-term effect of mass stool examination and treatment for decreasing all intestinal parasitic infection rates in Bolivian children are needed.


Asunto(s)
Entamebiasis/tratamiento farmacológico , Heces/parasitología , Giardiasis/tratamiento farmacológico , Helmintiasis/tratamiento farmacológico , Himenolepiasis/tratamiento farmacológico , Parasitosis Intestinales/tratamiento farmacológico , Parasitosis Intestinales/epidemiología , Tamizaje Masivo , Infecciones por Protozoos/epidemiología , Adolescente , Animales , Bolivia/epidemiología , Niño , Preescolar , Estudios Transversales , Entamoeba histolytica/aislamiento & purificación , Entamebiasis/epidemiología , Entamebiasis/parasitología , Entamebiasis/prevención & control , Femenino , Giardia lamblia/aislamiento & purificación , Giardiasis/epidemiología , Giardiasis/parasitología , Giardiasis/prevención & control , Helmintiasis/epidemiología , Helmintiasis/parasitología , Helmintiasis/prevención & control , Humanos , Himenolepiasis/epidemiología , Himenolepiasis/parasitología , Himenolepiasis/prevención & control , Hymenolepis/aislamiento & purificación , Parasitosis Intestinales/prevención & control , Masculino , Nitrocompuestos , Prevalencia , Estudiantes , Tiazoles/uso terapéutico , Adulto Joven
4.
Ann Agric Environ Med ; 21(3): 510-1, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25292119

RESUMEN

Hymenolepis diminuta is a cosmopolitan parasite of rats and mice which is very rare in humans. This study presents the case of a 3-year-old boy infected with Hymenolepis diminuta in Poland. The diagnosis was based on eggs found and their morphology in the patient's stool.


Asunto(s)
Himenolepiasis/prevención & control , Hymenolepis diminuta/aislamiento & purificación , Animales , Antihelmínticos/uso terapéutico , Preescolar , Heces/parasitología , Humanos , Himenolepiasis/tratamiento farmacológico , Himenolepiasis/parasitología , Hymenolepis diminuta/citología , Masculino , Óvulo/citología , Polonia , Praziquantel/uso terapéutico
6.
Kaohsiung J Med Sci ; 20(12): 575-9, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15696786

RESUMEN

Immunity to Taiwan Taenia infection in pigs can be stimulated using homologous or heterologous non-viable Taenia oncospheres. This study was designed to determine whether homologous non-viable oncospheres could stimulate immunity to Hymenolepis infection in rodents. Hatched oncospheres were prepared from eggs of Hymenolepis diminuta, Hymenolepis nana, and Hymenolepis microstoma and kept at -70 degrees C for more than 1 month. A mixture of 500 non-viable oncospheres of each tapeworm and complete Freund's adjuvant was injected subcutaneously in four groups of Sprague-Dawley rats or ICR mice one to four times at an interval of 1 week; controls were not immunized. After immunization, each rodent was orally inoculated with three fresh active cysticercoids of H. diminuta or H. microstoma or 500 fresh eggs of H. nana. The animals were then necropsied for adult tapeworms. No rats or mice immunized with non-viable oncospheres of H. diminuta or H. nana were infected by the challenge inoculation. However, 28 of 34 mice immunized with non-viable H. microstoma oncospheres were infected after inoculation with cysticercoids. This study demonstrated complete protection against infection by homologous parasites in rats or mice immunized with non-viable oncospheres of H. diminuta and H. nana, respectively. Repeated immunization may not be required if resistance is stimulated in rodent hosts.


Asunto(s)
Himenolepiasis/prevención & control , Hymenolepis/inmunología , Animales , Hymenolepis diminuta/inmunología , Hymenolepis nana/inmunología , Inmunización , Masculino , Ratones , Ratones Endogámicos ICR , Ratas , Ratas Sprague-Dawley
7.
Med Parazitol (Mosk) ; (4): 41-4, 2003.
Artículo en Ruso | MEDLINE | ID: mdl-14727492

RESUMEN

The authors review of researches into the influence of socioeconomic factors of development of the town (migration, urbanization, etc.) on the formation or reduction of hymenolepidosis foci. Emphasis is laid on various influences of the above factors on the distribution of hymenolepidiasis. The importance of helminthic control is well underlined. Annual medical examination of the whole population is considered to be the main prophylactic measure introduced into computer educational programs. The problems to be immediately solved by health administrators are outlined.


Asunto(s)
Himenolepiasis/prevención & control , Adolescente , Adulto , Animales , Niño , Preescolar , Emigración e Inmigración , Familia , Encuestas Epidemiológicas , Humanos , Himenolepiasis/epidemiología , Hymenolepis/aislamiento & purificación , Factores de Riesgo , Ucrania/epidemiología , Urbanización
8.
Am J Chin Med ; 26(2): 181-9, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9799970

RESUMEN

The chloroform extract of Tripterygium wilfordii Hook f (TWH extract) administered into mice daily at doses of 80.0 to 200.0 micrograms/kg (but not 40.0 micrograms/kg) caused suppression of protective immunity to Hymenolepis nana when the extract was injected subcutaneously during the induction phase of protective immunity. Daily administration of 200.0 micrograms/kg TWH extract, during the course of larval development from challenge, also suppressed protective immunity. Inhibition of protective immunity was only observed in mice that received TWH extract for 6 days at a daily dose of 200.0 micrograms/kg and were challenged 24 h after the final injection. TWH extract did not inhibit formation of effector cells that mediate delayed type hypersensitivity (DTH) to H. nana egg antigen when the extract was administered subcutaneously at a dose of 200.0 micrograms/kg/day for 5 days before cell preparation. However, TWH extract did inhibit DTH effector cell activation when cells prepared from infected, PBS-injected mice were transferred into 200.0 micrograms/kg TWH extract-treated recipient mice. These results strongly indicate that TWH extract cannot inhibit the generation of effector cells but will suppress their function in vivo.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Himenolepiasis/inmunología , Hymenolepis/inmunología , Inmunosupresores/farmacología , Activación de Linfocitos/efectos de los fármacos , Linfocitos T/efectos de los fármacos , Animales , Cloroformo , Modelos Animales de Enfermedad , Himenolepiasis/prevención & control , Hipersensibilidad Tardía , Masculino , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales , Linfocitos T/inmunología
9.
Med Parazitol (Mosk) ; (2): 46-8, 1998.
Artículo en Ruso | MEDLINE | ID: mdl-9691622

RESUMEN

Leukinferon administered before infection affects the development of a Hymenolepis nana population in the murine intestine: in rodents, its defective forms predominate over mature ones. Leukinferon caused cell prestimulation in the immune system and activation of nonspecific defense factors. The cytokine properties of the agent appear to have an impact on parasitic growth and development by leading to formation of defective Hymenolepis forms directly and indirectly through the host's body due to the prestimulation and enhancement of nonspecific defense. There may be a concurrent influence of these factors on H. nana embryos in the murine intestine.


Asunto(s)
Himenolepiasis/tratamiento farmacológico , Adyuvantes Inmunológicos/uso terapéutico , Animales , Anticestodos/uso terapéutico , Clorofenoles/uso terapéutico , Citocinas/uso terapéutico , Combinación de Medicamentos , Evaluación Preclínica de Medicamentos , Quimioterapia Combinada , Himenolepiasis/parasitología , Himenolepiasis/prevención & control , Hymenolepis/efectos de los fármacos , Hymenolepis/aislamiento & purificación , Interferón Tipo I/uso terapéutico , Intestino Delgado/parasitología , Larva/efectos de los fármacos , Ratones , Factores de Tiempo
10.
Int J Parasitol ; 27(11): 1437-43, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9421737

RESUMEN

The function of cytokines produced during Hymenolepis nana egg infection in mice in protective immunity against re-infection was examined. Treatment of mice with monoclonal antibody (MAb) against mouse interferon (IFN)-gamma caused suppression of protective immunity against H. nana re-infection when the MAb was injected intraperitoneally at a daily dose of 40.0 mg kg-1 during the effector phase of protective immunity. Although high levels of IFN-gamma, tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta were released into the intestinal tracts of the parasitised mice at challenge infection, there was almost no release of these cytokines in mice treated with the MAb. Daily administration of rolipram failed to suppress the protective immunity, even when 400 micrograms kg-1 of the agent was administered into mice during the effector phase of immunity. Treatment of mice with rolipram completely suppressed both TNF-alpha and IL-1 beta production in intestinal tracts, induced by H. nana challenge infection. However, endogenous IFN-gamma production in the intestine was scarcely affected by rolipram. These results strongly suggest that IFN-gamma is the most important (or essential) cytokine in protective immunity to H. nana re-infection, rather than TNF-alpha and IL-1 beta.


Asunto(s)
Himenolepiasis/inmunología , Interferón gamma/inmunología , Animales , Himenolepiasis/prevención & control , Hymenolepis/crecimiento & desarrollo , Hymenolepis/inmunología , Inmunidad Activa , Inmunosupresores/farmacología , Interferón gamma/biosíntesis , Interleucina-1/biosíntesis , Intestinos/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos ICR , Óvulo , Pirrolidinonas/farmacología , Rolipram , Factor de Necrosis Tumoral alfa/biosíntesis
12.
Parassitologia ; 33(1): 45-53, 1991 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-1841194

RESUMEN

Immunity in mammals to intestinal cestodes has been reviewed using the normal final host infected with the tapeworms Hymenolepis diminuta in rats and H. microstoma and H. nana in mice as a model. Primary infections up to a certain level continue to live as long the host, while most worms in infections with larger doses are destrobilated and expelled. It has been argued that concomitant immunity against a superimposed infection exists in rats and mice infected with H. diminuta and H. microstoma, respectively, and suggested that it also takes place in humans infected with Taenia spp. Immunity to secondary infections after expulsion of a primary infection occurs, but immunological memory is rather short-lived, although depression of worm growth occurs for at least two third of the rat's life. Serum antibodies have been shown to produce a direct precipitate on the surface of cestodes in vitro, but a direct effect of antibodies in vivo or the relationship with e.g. host effector cells, like mast cells and eosinophils, is unknown. It has been shown that peritoneal exudate cells from rats are able to kill H. diminuta in vitro. Very little is known about the mechanisms of tapeworms to counteract host immunological responses, but the tegumental glycoconjugates and discoidal secretory bodies are possible candidates. Passive transfer of immunity by mesenteric lymph node cells has only been successful using cells from H. nana egg-infected mice and has shown that only short-lived proliferating cells are responsible for transferring immunity. Vaccination procedures and problems are discussed with special reference to E. granulosus in dogs.


Asunto(s)
Himenolepiasis/inmunología , Hymenolepis/inmunología , Parasitosis Intestinales/inmunología , Vacunación , Animales , Anticuerpos Antihelmínticos/inmunología , Infecciones por Cestodos/inmunología , Infecciones por Cestodos/prevención & control , Cricetinae , Interacciones Huésped-Parásitos , Humanos , Himenolepiasis/prevención & control , Hymenolepis/clasificación , Hymenolepis/crecimiento & desarrollo , Huésped Inmunocomprometido , Memoria Inmunológica , Inmunoterapia Adoptiva , Parasitosis Intestinales/prevención & control , Ratones , Ratas , Especificidad de la Especie
15.
Med Parazitol (Mosk) ; (5): 3-10, 1989.
Artículo en Ruso | MEDLINE | ID: mdl-2615706

RESUMEN

Paper presents the data on the morbidity pattern of parasitic diseases in the USSR as well as on the trends in ascariasis, trichocephaliasis and hymenolepiasis infection rates. Problems of improving the prophylactic and antiepidemic measures are discussed with regard both to practical parasitology and investigations.


Asunto(s)
Enfermedades Parasitarias/epidemiología , Ascariasis/epidemiología , Ascariasis/prevención & control , Niño , Humanos , Himenolepiasis/epidemiología , Himenolepiasis/prevención & control , Enfermedades Parasitarias/prevención & control , Prevalencia , Factores Socioeconómicos , Tricuriasis/epidemiología , Tricuriasis/prevención & control , U.R.S.S./epidemiología
16.
Boll Ist Sieroter Milan ; 67(1): 62-5, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-3223997

RESUMEN

Under certain conditions, peritoneal exudate cells (PEC) removed from Hymenolepis nana-eggs infected mice, transferred to normal recipients severely inhibited the establishment of worms from a challenge infection, as expected in an immune state. A close relationship was observed between numbers of challenge worms and immune response. A significant effect was clearly demonstrable when the highest dose of eggs (150) was used, but the effect was less and not significant different when a smaller doses (30) was administered.


Asunto(s)
Exudados y Transudados/inmunología , Himenolepiasis/prevención & control , Hymenolepis/inmunología , Inmunización Pasiva , Animales , Líquido Ascítico , Ratones
19.
Rev. Inst. Med. Trop. Säo Paulo ; 27(1): 27-32, jan. - fev. 1985. tab
Artículo en Portugués | LILACS | ID: lil-1472

RESUMEN

Duas semanas após o insucesso da terapêutica com mebendazol - 400 mg diários durante quatro dias consecutivos -, 101 indivíduos de uma comunidade semifechada, 50,5% infectados por Hymenolepis nana, em sua maioria crianças entre dois e seis anos de idade, foram tratados com praziquantel (*) em duas doses orais de 20 a 25 mg/Kg, administradas com dez dias de intervalo. O diagnóstico da himenolepíase, bem como os controles de cura parasitológica realizados nos 7, 14, 21, 30, 60 e 90 dias depois da administraçäo da segunda dose de praziquantel, basearam-se em exames de fezes pelo método quantitativo de KATO/KATZ. A tolerância ao medicamento foi excelente e a negativaçäo dos exames ocorreu independentemente da intensidade do parasitismo. Nos 7 e 14 dias pós-tratamento encontraram-se ovos de H. nana, respectivamente em nove e em dois pacientes, mas esses ovos apresentavam-se distorcidos. No controle do 21 dia todos os resultados mostraram-se negativos, traduzindo um índice de cura de 100%. A partir do 30 dia verificou-se em três crianças a eliminaçäo de ovos normais do parasita. Tendo em vista serem essas as únicas que viviam em regime de semi-internaçäo nessa comunidade e a positividade tardia dos exames, esses casos foram considerados como reinfecçäo. Conclui-se, pelos resultados alcançados, que o esquema posológico empregado, fundamentado nas investigaçöes experimentais conduzidas por CAMPOS & col. (1983), é eficaz e seguro para o tratamento da himenolepíase, em especial, quando se pretende tentar erradicá-la numa comunidade fechada


Asunto(s)
Preescolar , Niño , Adolescente , Adulto , Persona de Mediana Edad , Humanos , Masculino , Femenino , Parasitosis Intestinales/tratamiento farmacológico , Himenolepiasis/tratamiento farmacológico , Praziquantel/uso terapéutico , Himenolepiasis/diagnóstico , Himenolepiasis/prevención & control , Hymenolepis/efectos de los fármacos , Recuento de Huevos de Parásitos
20.
Boll Ist Sieroter Milan ; 64(5): 408-13, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-4091979

RESUMEN

Mice immunized with antigens derived from Trichinella spiralis muscle larvae or Hymenolepis nana embryos were found to be protected against the homologous challenge infection. Intraperitoneal route was found the most effective in stimulating protection compared with subcutaneous or intravenous administration. Even a single dose of antigen administered intraperitoneally stimulated a significant protection. The results of our experiments confirm that the route of administration has a noteworthy influence on the effectiveness of the immunization. The possible mechanism involved in rejection of both worms population are discussed.


Asunto(s)
Hymenolepis/inmunología , Trichinella/inmunología , Vacunación , Animales , Antígenos Helmínticos/administración & dosificación , Antígenos Helmínticos/inmunología , Femenino , Himenolepiasis/prevención & control , Inyecciones Intraperitoneales , Inyecciones Subcutáneas , Larva/inmunología , Ratones , Triquinelosis/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...